| 0 |
BASAL CELL NAEVUS SYNDROME |
1 |
0.0435 |
| 1 |
FRACTURE PAIN |
1 |
0.0019 |
| 2 |
FIBROCYSTIC BREAST DISEASE |
1 |
0.0014 |
| 3 |
GINGIVAL ABSCESS |
1 |
0.0013 |
| 4 |
ANOGENITAL WARTS |
1 |
0.0011 |
| 5 |
BONE DEMINERALISATION |
1 |
0.0009 |
| 6 |
CHEMICAL BURN |
1 |
0.0009 |
| 7 |
APPLICATION SITE PARAESTHESIA |
1 |
0.0008 |
| 8 |
SKIN DEPIGMENTATION |
1 |
0.0007 |
| 9 |
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL |
1 |
0.0007 |
| 10 |
ANGIOPLASTY |
1 |
0.0007 |
| 11 |
POLYCYSTIC OVARIES |
1 |
0.0006 |
| 12 |
RESPIRATORY ALKALOSIS |
1 |
0.0006 |
| 13 |
QUADRIPARESIS |
1 |
0.0006 |
| 14 |
HYPOREFLEXIA |
1 |
0.0005 |
| 15 |
HEPATIC MASS |
1 |
0.0005 |
| 16 |
RENAL MASS |
1 |
0.0005 |
| 17 |
POST PROCEDURAL DISCOMFORT |
1 |
0.0005 |
| 18 |
MEDICAL DEVICE PAIN |
1 |
0.0005 |
| 19 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
1 |
0.0004 |
| 20 |
PRURITUS GENITAL |
1 |
0.0004 |
| 21 |
HYPERPARATHYROIDISM SECONDARY |
1 |
0.0004 |
| 22 |
ENDODONTIC PROCEDURE |
1 |
0.0004 |
| 23 |
RENAL CYST |
3 |
0.0004 |
| 24 |
WEIGHT BEARING DIFFICULTY |
1 |
0.0004 |
| 25 |
BONE MARROW DISORDER |
1 |
0.0003 |
| 26 |
HEPATIC NEOPLASM |
1 |
0.0003 |
| 27 |
PEPTIC ULCER |
1 |
0.0003 |
| 28 |
CERVICAL VERTEBRAL FRACTURE |
1 |
0.0003 |
| 29 |
APPLICATION SITE PAIN |
6 |
0.0003 |
| 30 |
GASTRIC INFECTION |
1 |
0.0003 |
| 31 |
SENSATION OF HEAVINESS |
1 |
0.0003 |
| 32 |
WOUND SECRETION |
1 |
0.0003 |
| 33 |
OESOPHAGEAL CANDIDIASIS |
1 |
0.0003 |
| 34 |
SKIN PAPILLOMA |
1 |
0.0002 |
| 35 |
BLEPHARITIS |
1 |
0.0002 |
| 36 |
ACCIDENTAL EXPOSURE |
1 |
0.0002 |
| 37 |
UTERINE PERFORATION |
2 |
0.0002 |
| 38 |
LUNG NEOPLASM |
1 |
0.0002 |
| 39 |
DYSPAREUNIA |
1 |
0.0002 |
| 40 |
ARTHRITIS INFECTIVE |
1 |
0.0002 |
| 41 |
APPLICATION SITE BURN |
1 |
0.0002 |
| 42 |
BENIGN PROSTATIC HYPERPLASIA |
1 |
0.0002 |
| 43 |
PRODUCT SIZE ISSUE |
1 |
0.0002 |
| 44 |
HYPERVENTILATION |
1 |
0.0002 |
| 45 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 46 |
SCOLIOSIS |
1 |
0.0002 |
| 47 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 48 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 49 |
DRUG TOXICITY |
2 |
0.0001 |
| 50 |
COORDINATION ABNORMAL |
2 |
0.0001 |
| 51 |
DUODENAL ULCER |
1 |
0.0001 |
| 52 |
HAND FRACTURE |
1 |
0.0001 |
| 53 |
FEELING DRUNK |
1 |
0.0001 |
| 54 |
FURUNCLE |
1 |
0.0001 |
| 55 |
MYASTHENIA GRAVIS |
1 |
0.0001 |
| 56 |
PSYCHOLOGICAL TRAUMA |
1 |
0.0001 |
| 57 |
SKIN SWELLING |
1 |
0.0001 |
| 58 |
ANHEDONIA |
3 |
0.0001 |
| 59 |
LOSS OF LIBIDO |
1 |
0.0001 |
| 60 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 61 |
AFFECT LABILITY |
1 |
0.0001 |
| 62 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 63 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 64 |
HYPOTONIA |
1 |
0.0001 |
| 65 |
EYE DISCHARGE |
1 |
0.0001 |
| 66 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 67 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 68 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 69 |
HAND DEFORMITY |
1 |
0.0001 |
| 70 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 71 |
HUNGER |
1 |
0.0001 |
| 72 |
PULMONARY ARTERIAL HYPERTENSION |
1 |
0.0001 |
| 73 |
INJECTION SITE HAEMATOMA |
1 |
0.0001 |
| 74 |
PULMONARY MASS |
1 |
0.0001 |
| 75 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 76 |
ANKLE FRACTURE |
1 |
0.0001 |
| 77 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 78 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 79 |
GOUT |
1 |
0.0001 |
| 80 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 81 |
DYSARTHRIA |
2 |
0.0001 |
| 82 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 83 |
OSTEOPOROSIS |
2 |
0.0000 |
| 84 |
TOOTH LOSS |
1 |
0.0000 |
| 85 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 86 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 87 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 88 |
DRUG INTERACTION |
7 |
0.0000 |
| 89 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 90 |
SKIN ULCER |
1 |
0.0000 |
| 91 |
EAR INFECTION |
1 |
0.0000 |
| 92 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 93 |
FEAR |
1 |
0.0000 |
| 94 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 95 |
TREMOR |
6 |
0.0000 |
| 96 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 97 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 98 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 99 |
RENAL INJURY |
1 |
0.0000 |
| 100 |
EMOTIONAL DISTRESS |
4 |
0.0000 |
| 101 |
FEELING HOT |
2 |
0.0000 |
| 102 |
HYPERSENSITIVITY |
6 |
0.0000 |
| 103 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 104 |
OSTEONECROSIS |
1 |
0.0000 |
| 105 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 106 |
GAIT INABILITY |
1 |
0.0000 |
| 107 |
INJURY |
2 |
0.0000 |
| 108 |
HYPOXIA |
1 |
0.0000 |
| 109 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 110 |
CRYING |
1 |
0.0000 |
| 111 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 112 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 113 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 114 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 115 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 116 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 117 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 118 |
MENTAL DISORDER |
1 |
0.0000 |
| 119 |
RENAL FAILURE |
3 |
0.0000 |
| 120 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 121 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 122 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 123 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 124 |
FLUID RETENTION |
1 |
0.0000 |
| 125 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 126 |
NERVOUSNESS |
1 |
0.0000 |
| 127 |
SPEECH DISORDER |
1 |
0.0000 |
| 128 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 129 |
DEPRESSION |
4 |
0.0000 |
| 130 |
ANXIETY |
5 |
0.0000 |
| 131 |
EYE IRRITATION |
1 |
0.0000 |
| 132 |
DISCOMFORT |
1 |
0.0000 |
| 133 |
CHEST PAIN |
3 |
0.0000 |
| 134 |
AMNESIA |
1 |
0.0000 |
| 135 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 136 |
BURNING SENSATION |
1 |
0.0000 |
| 137 |
SLEEP DISORDER |
1 |
0.0000 |
| 138 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 139 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 140 |
MOBILITY DECREASED |
1 |
0.0000 |
| 141 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 142 |
UNDERDOSE |
1 |
0.0000 |
| 143 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 144 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 145 |
PAIN |
8 |
0.0000 |
| 146 |
PRURITUS |
5 |
0.0000 |
| 147 |
BACK PAIN |
3 |
0.0000 |
| 148 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 149 |
DEVICE ISSUE |
1 |
0.0000 |
| 150 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 151 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 152 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 153 |
SWELLING |
1 |
0.0000 |
| 154 |
ASTHENIA |
4 |
0.0000 |
| 155 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 156 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 157 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 158 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 159 |
DYSPEPSIA |
1 |
0.0000 |
| 160 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 161 |
ERYTHEMA |
2 |
0.0000 |
| 162 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 163 |
INFLUENZA |
1 |
0.0000 |
| 164 |
SEPSIS |
1 |
0.0000 |
| 165 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 166 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 167 |
DECREASED APPETITE |
2 |
0.0000 |
| 168 |
FEELING ABNORMAL |
2 |
0.0000 |
| 169 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 170 |
INSOMNIA |
2 |
0.0000 |
| 171 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 172 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 173 |
RASH |
3 |
0.0000 |
| 174 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 175 |
HOSPITALISATION |
1 |
0.0000 |
| 176 |
URTICARIA |
1 |
0.0000 |
| 177 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 178 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 179 |
OFF LABEL USE |
5 |
0.0000 |
| 180 |
COVID-19 |
1 |
0.0000 |
| 181 |
MUSCLE SPASMS |
1 |
0.0000 |
| 182 |
ANAEMIA |
1 |
0.0000 |
| 183 |
ALOPECIA |
1 |
0.0000 |
| 184 |
SOMNOLENCE |
1 |
0.0000 |
| 185 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 186 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 187 |
ARTHRALGIA |
2 |
0.0000 |
| 188 |
HYPERTENSION |
1 |
0.0000 |
| 189 |
DRUG INEFFECTIVE |
6 |
0.0000 |
| 190 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 191 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 192 |
VOMITING |
2 |
0.0000 |
| 193 |
DYSPNOEA |
2 |
0.0000 |
| 194 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 195 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 196 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 197 |
DIARRHOEA |
2 |
0.0000 |
| 198 |
PNEUMONIA |
1 |
0.0000 |
| 199 |
FALL |
1 |
0.0000 |
| 200 |
PYREXIA |
1 |
0.0000 |
| 201 |
MALAISE |
1 |
0.0000 |
| 202 |
HEADACHE |
1 |
0.0000 |
| 203 |
NAUSEA |
1 |
0.0000 |